-transparent.png){kind=logo}
BACKGROUND Loss of heterozygosity (LOH) on chromosome arm 18q is common in sporadic prostate cancer and may be involved in cancer development through inactivation of tumor-suppressor genes (TSG). Recent identification, at 18q21.1, of MADR2/Smad2, a key component in transforming growth factor beta (TGFbeta)-family signaling pathways, led us to investigate the role of this gene in prostate tumorigenesis. METHODS Sporadic primary prostate tumors from 25 patients with clinically localized tumors and 7 with metastatic forms were examined for MADR2/Smad2 mutations by using polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) analysis of cDNA, and for gene expression by quantitative reverse transcription-polymerase chain reaction (RT-PCR). RESULTS We detected no mutation in MADR2/Smad2 and no abnormal mRNA expression. CONCLUSIONS Despite recent evidence indicating that MADR2/Smad2 acts as a tumor-suppressor gene, our findings suggest a limited role of this gene in prostate tumorigenesis, at least in the early stages. Another key tumor-suppressor gene may therefore be the main target of the observed LOH at 18q21.1.
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
September 1997,
Cancer research,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
August 1998,
The Prostate,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
February 2005,
Current opinion in genetics & development,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
July 1995,
Japanese journal of cancer research : Gann,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
April 2011,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
September 2000,
Cancer genetics and cytogenetics,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
October 2002,
Drugs of today (Barcelona, Spain : 1998),
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
December 2000,
Genes, chromosomes & cancer,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
January 2014,
Ukrainian biochemical journal,
A Latil, and
S Pesche, and
A Valéri, and
G Fournier, and
O Cussenot, and
R Lidereau
September 2004,
The Prostate,
